Top Markets
#1 Akedo Akedo +93.47%
#2 TENDIES TENDIES +74.83%
#3 Threshold Network Threshold Network +44.30%
#4 Verus Coin Verus Coin +43.84%
#5 MultiversX MultiversX +35.66%
#6 Mubarak Mubarak +32.96%
#7 Cash Cat Cash Cat +24.19%
#8 Bitway Bitway +23.60%
#9 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
#10 OSK OSK +16.18%
Coin of the day
Akedo Akedo
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Shukra Pharmaceuticals Limited Shukra Pharmaceuticals Limited

Shukra Pharmaceuticals Limited

SHUKRAPHAR
Clasificación en acciones #17792
Shukra Pharmaceuticals Limited is a prominent company engaged in the... Shukra Pharmaceuticals Limited is a prominent company engaged in the manufacturing and global distribution of pharmaceutical products. Their comprehensive product line addresses a broad spectrum of medical conditions, encompassing anti-infective medications (such as antibiotics, macrolides, quinolones, antivirals, antifungals, antimalarials, antiprotozoals, and anti-helminthics), central nervous system drugs (including sedatives, tranquilizers, antidepressants, and anti-manic agents), gastrointestinal treatments (like anti-emetics and anti-ulcer drugs), cardiovascular remedies (beta-blockers, diuretics), pain and inflammation management (analgesics, muscle relaxants, corticosteroids), anti-tuberculosis drugs, vitamin supplements, anti-allergy medications, and therapies for metabolic imbalances such as hyper- and hypoglycemia. The company was established on March 4, 1993, and its primary operations are directed from its headquarters in Ahmedabad, India.
Precio por acción
$0.51647906
Capitalización bursátil
$226.16M
Cambio (1 día)
5.29%
Cambio (1 año)
66.66%
País
IN
Comercio Shukra Pharmaceuticals Limited (SHUKRAPHAR)

Categoría

Healthcare
Ratio P/S de Shukra Pharmaceuticals Limited (SHUKRAPHAR)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Shukra Pharmaceuticals Limited, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Shukra Pharmaceuticals Limited desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
10.73 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
2.40 -
HK